Join Growin Stock Community!

Cbdmd, inc.YCBD.US Overview

US StockHealthcare
(No presentation for YCBD)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

YCBD AI Insights

YCBD Overall Performance

YCBD AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

YCBD Recent Performance

-4.01%

Cbdmd, inc.

0.05%

Avg of Sector

-0.31%

S&P500

YCBD PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

YCBD Key Information

YCBD Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

YCBD Profile

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.

Price of YCBD

YCBD FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

YCBD Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.22
PE Ratio (TTM)
1.45
Forward PE
-
PS Ratio (TTM)
0.50
PB Ratio
1.44
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
60.59%
Net Margin
-12.25%
Revenue Growth (YoY)
-0.66%
Profit Growth (YoY)
-2.28%
3-Year Revenue Growth
-6.23%
3-Year Profit Growth
-5.60%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.22
PE Ratio (TTM)
1.45
Forward PE
-
PS Ratio (TTM)
0.50
PB Ratio
1.44
Price-to-FCF
-
Gross Margin
60.59%
Net Margin
-12.25%
Revenue Growth (YoY)
-0.66%
Profit Growth (YoY)
-2.28%
3-Year Revenue Growth
-6.23%
3-Year Profit Growth
-5.60%
  • When is YCBD's latest earnings report released?

    The most recent financial report for Cbdmd, inc. (YCBD) covers the period of 2026Q1 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating YCBD's short-term business performance and financial health. For the latest updates on YCBD's earnings releases, visit this page regularly.

  • What is the operating profit of YCBD?

    According to the latest financial report, Cbdmd, inc. (YCBD) reported an Operating Profit of -286.29K with an Operating Margin of -5.71% this period, representing a decline of 231.84% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is YCBD's revenue growth?

    In the latest financial report, Cbdmd, inc. (YCBD) announced revenue of 5.02M, with a Year-Over-Year growth rate of -1.89%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does YCBD have?

    At the end of the period, Cbdmd, inc. (YCBD) held Total Cash and Cash Equivalents of 3.39M, accounting for 0.29 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does YCBD go with three margins increasing?

    In the latest report, Cbdmd, inc. (YCBD) did not achieve the “three margins increasing” benchmark, with a gross margin of 59.8%%, operating margin of -5.71%%, and net margin of -6.5%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess YCBD's profit trajectory and future growth potential.

  • Is YCBD's EPS continuing to grow?

    According to the past four quarterly reports, Cbdmd, inc. (YCBD)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.04. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of YCBD?

    Cbdmd, inc. (YCBD)'s Free Cash Flow (FCF) for the period is -977.27K, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 102.61% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.